The family of a Wisconsin man is suing after they say he died from an asthma attack when his medication price rose from $66 ...

Australia's Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included ...

BISMARCK, N.D. (KFYR) - Carrie Varner was diagnosed with the immunodeficiency disease Job’s Syndrome years ago. It can make ...

For many people suffering from asthma, the winter months and the colder air can trigger asthma symptoms and flare-ups, which ...

Medically reviewed by Daniel More, MD Many people with asthma as children go into long periods of remission, with infrequent ...

If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Of four treatment response measures recorded at 6 months of mepolizumab treatment, an Asthma Control Questionnaire score was ...

Although cost-related asthma treatment nonadherence has declined in the US, nearly 1 in 6 patients are still nonadherent due to cost concerns.

GSK (GSK) stock in focus as its experimental drug depemokimab undergoes EU review for asthma and nasal polyps. Read more here ...

Blue Cross Blue Shield company Health Care Service Corporation is limiting access for in-office administration of asthma ...